BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18603893)

  • 1. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatment.
    Douet-Guilbert N; Morel F; Le Charpentier T; Le Bris MJ; Herry A; Morice P; Bourquard P; Abgrall JF; Berthou C; De Braekeleer M
    Anticancer Res; 2004; 24(4):2535-9. PubMed ID: 15330210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow.
    Seong D; Thall P; Kantarjian HM; Talpaz M; Swantkowski J; Xu J; Shen Y; Glassman A; Ramagli L; Siciliano MJ
    Clin Cancer Res; 1998 Apr; 4(4):861-7. PubMed ID: 9563879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
    Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
    J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
    Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
    Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of interphase fluorescence in situ hybridization for determination of the tumor load in chronic myeloid leukemia].
    Du QF; Zhou SY; Liu XL; Song LL; Zhang Y
    Ai Zheng; 2003 Jun; 22(6):612-5. PubMed ID: 12948411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
    Schoch C; Schnittger S; Bursch S; Gerstner D; Hochhaus A; Berger U; Hehlmann R; Hiddemann W; Haferlach T
    Leukemia; 2002 Jan; 16(1):53-9. PubMed ID: 11840263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia].
    Zhu B; Shen X; Li C; Lai X; Li Y; Shi K; Feng H; Wang R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
    Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
    Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement.
    Oudat R; Khan Z; Glassman AB
    Ann Clin Lab Sci; 2001 Jan; 31(1):68-74. PubMed ID: 11314864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of BCRabl in Acute Leukemia by Molecular and Cytogenetic Methods.
    Wells SJ; Phillips CN; Farhi DC
    Mol Diagn; 1996 Dec; 1(4):305-313. PubMed ID: 10462577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.
    Döhner H; Stilgenbauer S; Fischer K; Schröder M; Bentz M; Lichter P
    Stem Cells; 1995 Dec; 13 Suppl 3():76-82. PubMed ID: 8747992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization.
    Chase A; Grand F; Zhang JG; Blackett N; Goldman J; Gordon M
    Genes Chromosomes Cancer; 1997 Apr; 18(4):246-53. PubMed ID: 9087564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.